- Trials with a EudraCT protocol (417)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (32)
417 result(s) found for: Necrosis.
Displaying page 1 of 21.
EudraCT Number: 2009-013431-38 | Sponsor Protocol Number: UF 8546 | Start Date*: 2009-11-20 | |||||||||||
Sponsor Name:CHRU Montpellier | |||||||||||||
Full Title: Etude ouverte prospective randomisée sur l’utilisation du Flammacérium® dans les nécroses cutanées ischémiques du pied | |||||||||||||
Medical condition: Nécrose cutanée ischémique du pied | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000618-23 | Sponsor Protocol Number: ORN-01 | Start Date*: 2015-05-05 | ||||||||||||||||
Sponsor Name:Västra Götalandsregionen/NÄL | ||||||||||||||||||
Full Title: Treatment of osteoradionecrosis (ORN) with pentoxifylline and α-tocopherol (PENTO) | ||||||||||||||||||
Medical condition: Osteoradionecrosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000887-32 | Sponsor Protocol Number: ORN-02 | Start Date*: 2015-07-20 | ||||||||||||||||
Sponsor Name:Västra Götalandsregionen/NÄL | ||||||||||||||||||
Full Title: Prophylactic treatment of osteoradionecrosis (ORN) with pentoxifylline and α-tocopherol (PENTO) | ||||||||||||||||||
Medical condition: Osteoradionecrosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022318-22 | Sponsor Protocol Number: tutkijalähtöinen tutkimus, | Start Date*: 2010-10-20 | |||||||||||
Sponsor Name:Maarit Valkealahti / University hospital of Oulu | |||||||||||||
Full Title: Tsoledronaatti hoito paikallista kiihtynyttä luunvaihdunta- oireyhtymää sairastavilla potilailla | |||||||||||||
Medical condition: Tässä tutkimuksessa esitetään bisfosfonaatti –lääkkeen käyttöä uusissa indikaatioissa. Haemme tällä tutkimussuunnitelmalla lupaa kliiniseen tutkimukseen, jossa selvitetään, mikä on lääkkeen teho h... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000886-35 | Sponsor Protocol Number: AloFem | Start Date*: 2018-06-27 | |||||||||||||||||||||
Sponsor Name:Enrique Gomez-Barrena | |||||||||||||||||||||||
Full Title: Evaluation of safety, feasibility and preliminary efficacy of MSCs from third party donors in the treatment of patients with osteonecrosis of the femoral head after allogeneic Stem Cell Transplanta... | |||||||||||||||||||||||
Medical condition: Osteonecrosis of the Femoral Head | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002010-39 | Sponsor Protocol Number: ORTHO-2 | Start Date*: 2014-04-11 | ||||||||||||||||
Sponsor Name:Universidad Autónoma de Madrid | ||||||||||||||||||
Full Title: Evaluation of safety and feasibility of bone marrow derived autologous MSCs to enhance bone healing in patients with avascular necrosis of femoral head | ||||||||||||||||||
Medical condition: Early avascular necrosis of the femoral head (MRI diagnosis): Ficat and Arlet 0, 1, or 2 (Steinberg stages 0, I, IIA, IIB, or IIC) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) IT (Ongoing) ES (Ongoing) RO (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000624-20 | Sponsor Protocol Number: ILONA | Start Date*: 2021-06-17 | |||||||||||
Sponsor Name:Leipzig University | |||||||||||||
Full Title: Core decompression versus core decompression followed by infusion of Iloprost in the treatment of non-traumatic avascular necrosis of the femoral head | |||||||||||||
Medical condition: non-traumatic avascular necrosis of the femoral head (N-ANFH) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019060-37 | Sponsor Protocol Number: CH.MAX-FACC.02/2009 | Start Date*: 2010-07-09 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | ||||||||||||||||||
Full Title: Clinical prospective study to evaluate the efficacy of hygienical therapy and metronidazole in addition to antibiotic therapy in patients affected by bisphosponate-associated osteonecrosis of the jaws | ||||||||||||||||||
Medical condition: patients affected by bisphosponate-associated osteonecrosis of the jaws and infection. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012929-11 | Sponsor Protocol Number: PREOB-ON3 | Start Date*: 2011-10-17 | |||||||||||
Sponsor Name:Bone Therapeutics S.A. | |||||||||||||
Full Title: Phase III, pivotal, multicentre, randomised, double-blind controlled Study to evaluate the Efficacy and Safety of Autologous Osteoblastic Cells (PREOB®) Implantation in Early Stage Non Traumatic Os... | |||||||||||||
Medical condition: Osteonecrosis of the Femoral Head | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) DE (Completed) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004301-41 | Sponsor Protocol Number: P170404J | Start Date*: 2018-10-15 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS [...] | |||||||||||||
Full Title: FURosemide Stress Test to predict need of Renal Replacement THERapy in Ischemic Acute Tubular Necrosis in Intensive Care Units | |||||||||||||
Medical condition: FURosemide Stress Test to predict need of Renal Replacement THERapy in Ischemic Acute Tubular Necrosis in Intensive Care Units | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001920-36 | Sponsor Protocol Number: NIMAO/2018-01/JF-01 | Start Date*: 2020-12-03 | |||||||||||
Sponsor Name:CHU de NIMES | |||||||||||||
Full Title: Phase II a study to evaluate the safety, tolerability, distribution and dose effect of neoadjuvant doxorubicin arterial embolization in patients with prostate cancer at high risk of recurrence befo... | |||||||||||||
Medical condition: patients with high-risk prostate cancer with a Gleason score of 9-10 on biopsy,multimodal treatment radical prostatectomy validated in CPR, managed in Hospital of Nîmes. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003972-64 | Sponsor Protocol Number: 2015-09 | Start Date*: 2019-07-02 |
Sponsor Name:ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE | ||
Full Title: Plasma and tissue pharmacokinetics of amikacin administrated by dressing impregnated in burns patients | ||
Medical condition: burns patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002798-21 | Sponsor Protocol Number: 13337 | Start Date*: 2018-06-19 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: A multi-centre, blinded, randomised, placebo-controlled trial assessing the clinical and cost effectiveness of a 12 month course of oral alendronate (70mg weekly) in patients presenting with avascu... | |||||||||||||
Medical condition: Early stage (Ficat 1 or 2), symptomatic, Avascular Necrosis (AVN) of the femoral head | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000623-73 | Sponsor Protocol Number: LIDO | Start Date*: 2016-09-29 |
Sponsor Name:FUNDACIÓN INVESTIGACIÓN BIOMÉDICA HOSPITAL PUERTA DE HIERRO | ||
Full Title: LIDOCAINE IN ISCHEMIA-REPERFUSION INJURY FROM MICROSURGICAL BREAST RECONSTRUCTION. RANDOMISED UNICENTRIC, DOUBLE-BLIND, CLINICAL, CONTROLLED TRIAL. | ||
Medical condition: Ischemia-reperfusion injury from breast reconstruction microsurgical flaps. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001455-40 | Sponsor Protocol Number: GRECCO-19 | Start Date*: 2020-04-01 | |||||||||||
Sponsor Name:Hellenic Society of Rhythmology | |||||||||||||
Full Title: The Greek study in the Effects of Colchicine in Covid-19 complications prevention | |||||||||||||
Medical condition: This trial will investigate if colchicine could potentially have an effect in patients’ clinical course by limiting the myocardial necrosis and pneumonia development in the context of COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000515-14 | Sponsor Protocol Number: GPIAP | Start Date*: 2008-01-21 |
Sponsor Name:AZIENDA SANITARIA LOCALE 9 DI GROSSETO | ||
Full Title: Utility og GPIIb/IIIa inhibitor in patients with medium-low clinical risk but with high risk of periprocedural necrosis in coronary lesion. | ||
Medical condition: Patients with medium-low clinical risk but with high risk of periprocedural necrosis in coronary lesion. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001532-11 | Sponsor Protocol Number: 01apr2014 | Start Date*: 2014-09-11 |
Sponsor Name:Ospedale San Raffaele | ||
Full Title: MONO-INSTITUTIONAL PHASE II TRIAL ADDRESSING TOLERABILITY AND ACTIVITY OF R-CHOP CHEMOIMMUNOTHERAPY PRECEDED BY BLOOD-BRAIN BARRIER PERMEABILIZATION BY NGR-TUMOR NECROSIS FACTOR IN PATIENTS WITH RE... | ||
Medical condition: Primary non-Hodgkin lymphoma in the central nervous system relapse / refractory | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-005582-36 | Sponsor Protocol Number: SIM-07-003 | Start Date*: 2008-04-07 |
Sponsor Name:DEFIANTE FARMACEUTICA,LDA | ||
Full Title: A RANDOMIZED MULTICENTRE PHASE II STUDY TESTING TOLERABILITY AND EFFICACY ON SURROGATE ENDPOINTS (LIPID PROFILE, VASCULAR INFLAMMATORY MARKERS AND THROMBOGENESIS) OF SIMVAPUFA FORMULATION (ASSOCIAT... | ||
Medical condition: For this study, patients with acute coronary syndrome STEMI (ST-Elevation Myocardial Infarction and NSTEMI (Non-ST-Elevation Myocardial Infarction), occurred within the previous 72 hours with posit... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-005573-21 | Sponsor Protocol Number: GLIOMARK1 | Start Date*: 2016-04-26 | |||||||||||
Sponsor Name:pro-ACTINA S.A. | |||||||||||||
Full Title: Exploratory phase II study in patients after treatment of high grade brain tumors to assess the technical performance of Tc-99m tetrofosmin for differentiation of recurrence versus radiation necrosis | |||||||||||||
Medical condition: Patients with high grade brain tumors | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004921-40 | Sponsor Protocol Number: 004SC08166 | Start Date*: 2008-12-09 | |||||||||||
Sponsor Name:ANGELINI | |||||||||||||
Full Title: A pilot study to evaluate the efficacy and safety of different bindarit dosages in preventing stent restenosis | |||||||||||||
Medical condition: PATIENTS WITH BARE METAL STENT IMPLANT | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.